Patient-reported outcomes, neurocognitive functioning and oncologic results of pencil-beam-scanning proton beam therapy for CNS WHO G2 and G3 IDH1-mutant diffuse adult glioma : A single institution experience
Recent Publication
A new study from KL's research and teaching centre, MedAustron, shows that proton therapy can be effective in treating certain brain tumours (IDH-mutated gliomas): The researchers have investigated how the treatment affects quality of life, memory and disease progression. The results are promising: most patients were still alive five years after treatment without a relapse and their quality of life remained stable. Many patients' thinking and memory were even better than before.
Pelak, D. M. J., Hummer, A., Hug, P. E., Töpfer, S., Birgit Flechl, I., Mozes, P., Fossati, P. P., Fussl, C., Surböck, B., Hainfellner, P. J., Wolfsberger, P. S., Purkart, T. U., Calabek-Wohinz, B., Mumot, M., Stock, P. M., & Lütgendorf-Caucig, C. (2025). Patient-reported outcomes, neurocognitive functioning and oncologic results of pencil-beam-scanning proton beam therapy for CNS WHO G2 and G3 IDH1-mutant diffuse adult glioma: A single institution experience. International Journal of Radiation Oncology Biology Physics. Advance online publication. https://doi.org/10.1016/j.ijrobp.2025.10.025
Univ.-Prof. PD DI Markus Stock PhD
Head of
Department of Medical Physics with an emphasis on Particle Therapy
Univ.-Prof. Dr. Piero Fossati MD
Head of
Department of Radiation Oncology with an emphasis on Particle Therapy
OÄ Dr. Bernadette Calabek-Wohinz
Division of Neurology (University Hospital St. Pölten)